Analysis and Commentary STEVEN GROSSMAN 9/26/14 Analysis and Commentary STEVEN GROSSMAN 9/26/14 An X-Like Prize for Regulatory Science Read More Analysis and Commentary STEVEN GROSSMAN 9/19/14 Analysis and Commentary STEVEN GROSSMAN 9/19/14 What May the Road Look Like Come November? Read More Analysis and Commentary STEVEN GROSSMAN 9/12/14 Analysis and Commentary STEVEN GROSSMAN 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More Analysis and Commentary STEVEN GROSSMAN 3/1/13 Analysis and Commentary STEVEN GROSSMAN 3/1/13 And So It Begins ... Read More Analysis and Commentary STEVEN GROSSMAN 2/25/13 Analysis and Commentary STEVEN GROSSMAN 2/25/13 Sequestration and Its Consequences -- A Short Q&A Read More Analysis and Commentary STEVEN GROSSMAN 2/15/13 Analysis and Commentary STEVEN GROSSMAN 2/15/13 Chaos, Dysfunction, and Two Certainties Read More Analysis and Commentary STEVEN GROSSMAN 2/8/13 Analysis and Commentary STEVEN GROSSMAN 2/8/13 Alliance Still Committed to Protecting FDA from Sequestration Read More Analysis and Commentary STEVEN GROSSMAN 1/19/13 Analysis and Commentary STEVEN GROSSMAN 1/19/13 Sequestration: Still the Wrong Direction Read More Analysis and Commentary STEVEN GROSSMAN 1/11/13 Analysis and Commentary STEVEN GROSSMAN 1/11/13 Points to Keep in Mind for Next 8 Weeks Read More Analysis and Commentary STEVEN GROSSMAN 12/21/12 Analysis and Commentary STEVEN GROSSMAN 12/21/12 And the sequestration clock is STILL ticking ... Read More Analysis and Commentary STEVEN GROSSMAN 12/14/12 Analysis and Commentary STEVEN GROSSMAN 12/14/12 Tick ... Tick ... Tick ... Tick ... Tick ... Read More Analysis and Commentary STEVEN GROSSMAN 12/7/12 Analysis and Commentary STEVEN GROSSMAN 12/7/12 Many Unknowns and Just a Few Certainties Read More Analysis and Commentary STEVEN GROSSMAN 11/30/12 Analysis and Commentary STEVEN GROSSMAN 11/30/12 Is an Omnibus FY 13 Appropriations Bill a Real Possibility? Read More Analysis and Commentary STEVEN GROSSMAN 11/16/12 Analysis and Commentary STEVEN GROSSMAN 11/16/12 The Alliance Will Push, Pull, Remind, and Cajole to Ensure that FDA Can Meet Its Mission Read More Analysis and Commentary STEVEN GROSSMAN 11/9/12 Analysis and Commentary STEVEN GROSSMAN 11/9/12 Time for Some Constructive, Bipartisan Conversations Read More Analysis and Commentary STEVEN GROSSMAN 10/26/12 Analysis and Commentary STEVEN GROSSMAN 10/26/12 "There is No Secret Pre-election Budget Deal" Read More Analysis and Commentary STEVEN GROSSMAN 10/19/12 Analysis and Commentary STEVEN GROSSMAN 10/19/12 Who'll Get the Work Done ... And How Fast? Read More Analysis and Commentary STEVEN GROSSMAN 10/12/12 Analysis and Commentary STEVEN GROSSMAN 10/12/12 Why the Alliance Goes to Bat ... Over and Over Again Read More Analysis and Commentary STEVEN GROSSMAN 9/23/12 Analysis and Commentary STEVEN GROSSMAN 9/23/12 The Impact of Sequestration: An Update and Commentary Read More Analysis and Commentary STEVEN GROSSMAN 9/14/12 Analysis and Commentary STEVEN GROSSMAN 9/14/12 A Large and Unequal Hit on the FDA Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 9/26/14 Analysis and Commentary STEVEN GROSSMAN 9/26/14 An X-Like Prize for Regulatory Science Read More
Analysis and Commentary STEVEN GROSSMAN 9/19/14 Analysis and Commentary STEVEN GROSSMAN 9/19/14 What May the Road Look Like Come November? Read More
Analysis and Commentary STEVEN GROSSMAN 9/12/14 Analysis and Commentary STEVEN GROSSMAN 9/12/14 Agency Growth ... And Macro-Budgetary Politics Read More
Analysis and Commentary STEVEN GROSSMAN 3/1/13 Analysis and Commentary STEVEN GROSSMAN 3/1/13 And So It Begins ... Read More
Analysis and Commentary STEVEN GROSSMAN 2/25/13 Analysis and Commentary STEVEN GROSSMAN 2/25/13 Sequestration and Its Consequences -- A Short Q&A Read More
Analysis and Commentary STEVEN GROSSMAN 2/15/13 Analysis and Commentary STEVEN GROSSMAN 2/15/13 Chaos, Dysfunction, and Two Certainties Read More
Analysis and Commentary STEVEN GROSSMAN 2/8/13 Analysis and Commentary STEVEN GROSSMAN 2/8/13 Alliance Still Committed to Protecting FDA from Sequestration Read More
Analysis and Commentary STEVEN GROSSMAN 1/19/13 Analysis and Commentary STEVEN GROSSMAN 1/19/13 Sequestration: Still the Wrong Direction Read More
Analysis and Commentary STEVEN GROSSMAN 1/11/13 Analysis and Commentary STEVEN GROSSMAN 1/11/13 Points to Keep in Mind for Next 8 Weeks Read More
Analysis and Commentary STEVEN GROSSMAN 12/21/12 Analysis and Commentary STEVEN GROSSMAN 12/21/12 And the sequestration clock is STILL ticking ... Read More
Analysis and Commentary STEVEN GROSSMAN 12/14/12 Analysis and Commentary STEVEN GROSSMAN 12/14/12 Tick ... Tick ... Tick ... Tick ... Tick ... Read More
Analysis and Commentary STEVEN GROSSMAN 12/7/12 Analysis and Commentary STEVEN GROSSMAN 12/7/12 Many Unknowns and Just a Few Certainties Read More
Analysis and Commentary STEVEN GROSSMAN 11/30/12 Analysis and Commentary STEVEN GROSSMAN 11/30/12 Is an Omnibus FY 13 Appropriations Bill a Real Possibility? Read More
Analysis and Commentary STEVEN GROSSMAN 11/16/12 Analysis and Commentary STEVEN GROSSMAN 11/16/12 The Alliance Will Push, Pull, Remind, and Cajole to Ensure that FDA Can Meet Its Mission Read More
Analysis and Commentary STEVEN GROSSMAN 11/9/12 Analysis and Commentary STEVEN GROSSMAN 11/9/12 Time for Some Constructive, Bipartisan Conversations Read More
Analysis and Commentary STEVEN GROSSMAN 10/26/12 Analysis and Commentary STEVEN GROSSMAN 10/26/12 "There is No Secret Pre-election Budget Deal" Read More
Analysis and Commentary STEVEN GROSSMAN 10/19/12 Analysis and Commentary STEVEN GROSSMAN 10/19/12 Who'll Get the Work Done ... And How Fast? Read More
Analysis and Commentary STEVEN GROSSMAN 10/12/12 Analysis and Commentary STEVEN GROSSMAN 10/12/12 Why the Alliance Goes to Bat ... Over and Over Again Read More
Analysis and Commentary STEVEN GROSSMAN 9/23/12 Analysis and Commentary STEVEN GROSSMAN 9/23/12 The Impact of Sequestration: An Update and Commentary Read More
Analysis and Commentary STEVEN GROSSMAN 9/14/12 Analysis and Commentary STEVEN GROSSMAN 9/14/12 A Large and Unequal Hit on the FDA Read More
